ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - etravirine 200mg - tablet - 200 mg - active: etravirine 200mg excipient: colloidal silicon dioxide croscarmellose sodium hypromellose as a spray dried powder silicified microcrystalline cellulose magnesium stearate microcrystalline cellulose - etravirine, in combination with other antiretroviral agents is indicated for the treatment of hiv-1 infection in antiretroviral treatment-experienced adults who have evidence of viral replication and resistance to non-nucleoside transcriptase inhibitors and other antiretroviral agents.

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - paclitaxel 6 mg/ml;   - concentrate for infusion - 6 mg/ml - active: paclitaxel 6 mg/ml   excipient: ethanol polyoxyl 35 castor oil - primary treatment of ovarian cancer in combination with a platinum agent. treatment of metastatic ovarian cancer after failure of standard therapy.

ישראל - אנגלית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - sildenafil as citrate - film coated tablets - sildenafil as citrate 20 mg - sildenafil - sildenafil - for adults > 18 years: treatment of primary pulmonary hypertension (pph) pulmonary hypertension (ph) associated with connective tissue disease (ctd) or ph following surgical repair at least 5 years previously of atrial septal defect (asd) ventricular septal defect (vsd) patent ductus arteriosus (pda) or aorto-pulmonary window.

ישראל - אנגלית - Ministry of Health

neopharm scientific ltd - lenalidomide - hard capsule - lenalidomide 5 mg - lenalidomide - lenalidomide - multiple myeloma (mm) revlimid is indicated for the treatment of multiple myeloma.myelodysplastic syndromes revlimid is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (mds) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.revlimid 7.5 mg is not indicated for treatment in mds.mantle cell lymphomarevlimid is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (mcl).follicular lymphomarevlimid in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.

ישראל - אנגלית - Ministry of Health

neopharm scientific ltd - lenalidomide - hard capsule - lenalidomide 5 mg - lenalidomide - lenalidomide - multiple myeloma (mm) revlimid is indicated for the treatment of multiple myeloma.myelodysplastic syndromes revlimid is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (mds) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.revlimid 7.5 mg is not indicated for treatment in mds.mantle cell lymphomarevlimid is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (mcl).follicular lymphomarevlimid in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.

ישראל - אנגלית - Ministry of Health

neopharm scientific ltd - lenalidomide - hard capsule - lenalidomide 10 mg - lenalidomide - lenalidomide - multiple myeloma (mm) revlimid is indicated for the treatment of multiple myeloma.myelodysplastic syndromes revlimid is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (mds) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.revlimid 7.5 mg is not indicated for treatment in mds.mantle cell lymphomarevlimid is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (mcl).follicular lymphomarevlimid in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.

ישראל - אנגלית - Ministry of Health

neopharm scientific ltd - lenalidomide - hard capsule - lenalidomide 10 mg - lenalidomide - lenalidomide - multiple myeloma (mm)revlimid is indicated for the treatment of multiple myeloma.myelodysplastic syndromes revlimid is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (mds) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.revlimid 7.5 mg is not indicated for treatment in mds.mantle cell lymphomarevlimid is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (mcl).follicular lymphomarevlimid in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.

ישראל - אנגלית - Ministry of Health

neopharm scientific ltd - lenalidomide - hard capsule - lenalidomide 15 mg - lenalidomide - lenalidomide - multiple myeloma (mm)revlimid is indicated for the treatment of multiple myeloma.myelodysplastic syndromes revlimid is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (mds) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.revlimid 7.5 mg is not indicated for treatment in mds.mantle cell lymphomarevlimid is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (mcl).follicular lymphomarevlimid in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.

ישראל - אנגלית - Ministry of Health

neopharm scientific ltd - lenalidomide - hard capsule - lenalidomide 15 mg - lenalidomide - lenalidomide - multiple myeloma (mm)revlimid is indicated for the treatment of multiple myeloma.myelodysplastic syndromes revlimid is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (mds) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.revlimid 7.5 mg is not indicated for treatment in mds.mantle cell lymphomarevlimid is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (mcl).follicular lymphomarevlimid in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.

ישראל - אנגלית - Ministry of Health

neopharm scientific ltd - lenalidomide - hard capsule - lenalidomide 25 mg - lenalidomide - lenalidomide - multiple myeloma (mm)revlimid is indicated for the treatment of multiple myeloma.myelodysplastic syndromes revlimid is indicated for patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (mds) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.revlimid 7.5 mg is not indicated for treatment in mds.mantle cell lymphomarevlimid is indicated for the treatment of adult patients with relapsed and/or refractory mantle cell lymphoma (mcl).follicular lymphomarevlimid in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma.